Populatie-impact van risicogebaseerde longkankerscreening op laatadiagnostiek in Greater Manchester

Low-dose computed tomography screening reduces lung cancer mortality in clinical trials, but evidence of impact in real-world programs is lacking. Here, we evaluate the impact of screening in a socio-economically deprived area at the population level. We hypothesized that late-stage lung cancer incidence, as a surrogate for lung cancer mortality, would decrease after systematic implementation of screening in a high-risk population.